Biogen
Innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases.
Launch date
Employees
Market cap
CAD39.3b
Enterprise valuation
CAD45.8b (Public information from Sep 2024)
Share price
$201.44 BIIB
Cambridge Massachusetts (HQ)
Corporate Venture Fund: Biogen Idec New Ventures
No columns specified